110 related articles for article (PubMed ID: 1581219)
1. Transfer of specific immunity from donor to recipient of an allogeneic bone marrow graft: effect of conditioning on the specific immune response of the graft recipient.
Labadie J; van Tol MJ; Dijkstra NH; Zwaan FE; Vossen JM
Br J Haematol; 1992 Mar; 80(3):381-90. PubMed ID: 1581219
[TBL] [Abstract][Full Text] [Related]
2. Transfer of specific immunity from donor to recipient of an allogeneic bone marrow graft: evidence for donor origin of the antibody producing cells.
Labadie J; van Tol MJ; Dijkstra NH; van der Kaaden M; Jol-van der Zijde CM; de Lange GG; Zwaan FE; Vossen JM
Br J Haematol; 1992 Oct; 82(2):437-44. PubMed ID: 1419826
[TBL] [Abstract][Full Text] [Related]
3. Immune transfer studies in canine allogeneic marrow graft donor-recipient pairs.
Grosse-Wilde H; Krumbacher K; Schüning F; Doxiadis I; Mahmoud HK; Emde C; Schmidt-Weinmar A; Schaefer UW
Transplantation; 1986 Jul; 42(1):64-7. PubMed ID: 3523884
[TBL] [Abstract][Full Text] [Related]
4. The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients.
Lum LG; Seigneuret MC; Storb R
J Clin Immunol; 1986 Sep; 6(5):389-96. PubMed ID: 2429980
[TBL] [Abstract][Full Text] [Related]
5. Clonal dysregulation of the antibody response to tetanus-toxoid after bone marrow transplantation.
Gerritsen EJ; Van Tol MJ; Van 't Veer MB; Wels JM; Khouw IM; Touw CR; Jol-Van Der Zijde CM; Hermans J; Rümke HC; Radl J
Blood; 1994 Dec; 84(12):4374-82. PubMed ID: 7994052
[TBL] [Abstract][Full Text] [Related]
6. Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans.
Kodo H; Gale RP; Saxon A
J Clin Invest; 1984 May; 73(5):1377-84. PubMed ID: 6609170
[TBL] [Abstract][Full Text] [Related]
7. Designed transfer of specific immune responses with bone marrow transplantation.
Saxon A; Mitsuyasu R; Stevens R; Champlin RE; Kimata H; Gale RP
J Clin Invest; 1986 Oct; 78(4):959-67. PubMed ID: 3531239
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific antibody responses of lymphocytes to tetanus toxoid after human marrow transplantation.
Shiobara S; Lum LG; Witherspoon RP; Storb R
Transplantation; 1986 May; 41(5):587-92. PubMed ID: 2939606
[TBL] [Abstract][Full Text] [Related]
9. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
[TBL] [Abstract][Full Text] [Related]
10. The detection of specific antibody formation to recall antigens after human bone marrow transplantation.
Lum LG; Munn NA; Schanfield MS; Storb R
Blood; 1986 Mar; 67(3):582-7. PubMed ID: 3511982
[TBL] [Abstract][Full Text] [Related]
11. [Control of interstitial pneumonia with the application of immune transfer].
Otsuka M; Mori T
Rinsho Ketsueki; 1990 May; 31(5):584-8. PubMed ID: 2168493
[TBL] [Abstract][Full Text] [Related]
12. Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow.
Wimperis JZ; Brenner MK; Prentice HG; Reittie JE; Karayiannis P; Griffiths PD; Hoffbrand AV
Lancet; 1986 Feb; 1(8477):339-43. PubMed ID: 2868294
[TBL] [Abstract][Full Text] [Related]
13. [Kinetics of vaccine antibodies to tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococci after allogenic and autologous bone marrow transplantation and booster immunization. 1: The kinetics of vaccine antibodies to tetanus toxoid after allogenic and autologous bone marrow transplantation].
Prager J; Baumert A; Hermann J; Fuchs D; Zintl F
Kinderarztl Prax; 1992 Jun; 60(4-5):124-30. PubMed ID: 1495263
[TBL] [Abstract][Full Text] [Related]
14. B cell development and regulation after T cell-depleted marrow transplantation.
Wimperis JZ; Brenner MK; Prentice HG; Thompson EJ; Hoffbrand AV
J Immunol; 1987 Apr; 138(8):2445-50. PubMed ID: 3549902
[TBL] [Abstract][Full Text] [Related]
15. Requirements for the adoptive transfer of antibody responses to a priming antigen in man.
Wimperis JZ; Gottlieb D; Duncombe AS; Heslop HE; Prentice HG; Brenner MK
J Immunol; 1990 Jan; 144(2):541-7. PubMed ID: 2136894
[TBL] [Abstract][Full Text] [Related]
16. IgG anti-tetanus toxoid antibody production induced by Epstein-Barr virus from B cells of human marrow transplant recipients.
Jin NR; Lum LG
Cell Immunol; 1986 Aug; 101(1):266-73. PubMed ID: 2427210
[TBL] [Abstract][Full Text] [Related]
17. [Antigen-specific antibody response in allogeneic bone marrow transplantation patients: in vivo and in vitro antibody production after the primary immunization with tetanus toxoid. Kanazawa University Bone Marrow Transplantation Team].
Otsuka M; Shiobara S; Harada M; Ueda M; Mori T; Matsue K; Matsuda T
Rinsho Ketsueki; 1990 Mar; 31(3):301-7. PubMed ID: 2366332
[TBL] [Abstract][Full Text] [Related]
18. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation.
Ljungman P; Wiklund-Hammarsten M; Duraj V; Hammarström L; Lönnqvist B; Paulin T; Ringdén O; Pepe MS; Gahrton G
J Infect Dis; 1990 Aug; 162(2):496-500. PubMed ID: 2197342
[TBL] [Abstract][Full Text] [Related]
19. Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors.
Ilan Y; Nagler A; Shouval D; Ackerstein A; Or R; Kapelushnik J; Adler R; Slavin S
Clin Exp Immunol; 1994 Aug; 97(2):299-302. PubMed ID: 8050180
[TBL] [Abstract][Full Text] [Related]
20. Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation.
Boland GJ; Vlieger AM; Ververs C; De Gast GC
Clin Exp Immunol; 1992 Jun; 88(3):506-11. PubMed ID: 1318805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
